Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent disease without any approved treatment to-date despite intensive research efforts by researchers and pharmaceutical industry. Fibroblast growth factor (FGF)-21 has been gaining increasing attention as a possible contributing factor and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Raptis, Dimitrios D, Mantzoros, Christos S, Polyzos, Stergios A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879042/
https://www.ncbi.nlm.nih.gov/pubmed/36713291
http://dx.doi.org/10.2147/TCRM.S352008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879042/
https://www.ncbi.nlm.nih.gov/pubmed/36713291
http://dx.doi.org/10.2147/TCRM.S352008

Ejemplares similares